These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 36748565)

  • 21. Airway host-microbiome interactions in chronic obstructive pulmonary disease.
    Wang Z; Maschera B; Lea S; Kolsum U; Michalovich D; Van Horn S; Traini C; Brown JR; Hessel EM; Singh D
    Respir Res; 2019 Jun; 20(1):113. PubMed ID: 31170986
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Longitudinal Associations of the Cystic Fibrosis Airway Microbiome and Volatile Metabolites: A Case Study.
    Hahn A; Whiteson K; Davis TJ; Phan J; Sami I; Koumbourlis AC; Freishtat RJ; Crandall KA; Bean HD
    Front Cell Infect Microbiol; 2020; 10():174. PubMed ID: 32411616
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The altered sputum microbiome profile in patients with moderate and severe COPD exacerbations, compared to the healthy group in the Indian population.
    Hazra D; Sm F; Chawla K; Sintchenko V; Martinez E; Magazine R; Siddalingaiah N
    F1000Res; 2023; 12():528. PubMed ID: 37928173
    [No Abstract]   [Full Text] [Related]  

  • 24. Seasonal Dynamics of the Upper Respiratory Tract Microbiome in Chronic Obstructive Pulmonary Disease.
    Cai S; Gao J; Liu X; Yang J; Feng D; Li G; Li S; Yang H; Wang Z; Yi X; Zhou Y
    Int J Chron Obstruct Pulmon Dis; 2023; 18():1267-1276. PubMed ID: 37362620
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The fungal airway microbiome in cystic fibrosis and non-cystic fibrosis bronchiectasis.
    Cuthbertson L; Felton I; James P; Cox MJ; Bilton D; Schelenz S; Loebinger MR; Cookson WOC; Simmonds NJ; Moffatt MF
    J Cyst Fibros; 2021 Mar; 20(2):295-302. PubMed ID: 32540174
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The presence of cystic fibrosis-related diabetes modifies the sputum microbiome in cystic fibrosis disease.
    Vasiljevs S; Witney AA; Baines DL
    Am J Physiol Lung Cell Mol Physiol; 2024 Feb; 326(2):L125-L134. PubMed ID: 38084404
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Culture enriched molecular profiling of the cystic fibrosis airway microbiome.
    Sibley CD; Grinwis ME; Field TR; Eshaghurshan CS; Faria MM; Dowd SE; Parkins MD; Rabin HR; Surette MG
    PLoS One; 2011; 6(7):e22702. PubMed ID: 21829484
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Endotyping Chronic Obstructive Pulmonary Disease, Bronchiectasis, and the "Chronic Obstructive Pulmonary Disease-Bronchiectasis Association".
    Huang JT; Cant E; Keir HR; Barton AK; Kuzmanova E; Shuttleworth M; Pollock J; Finch S; Polverino E; Bottier M; Dicker AJ; Shoemark A; Chalmers JD
    Am J Respir Crit Care Med; 2022 Aug; 206(4):417-426. PubMed ID: 35436182
    [No Abstract]   [Full Text] [Related]  

  • 29. Design and Development of a Model to Study the Effect of Supplemental Oxygen on the Cystic Fibrosis Airway Microbiome.
    Vieira J; Gallagher T; Sui HY; Jesudasen S; Whiteson K; O'Toole GA; Hanselmann K; Lai PS
    J Vis Exp; 2021 Aug; (174):. PubMed ID: 34424248
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Loss of Airway Phylogenetic Diversity Is Associated with Clinical and Pathobiological Markers of Disease Development in Chronic Obstructive Pulmonary Disease.
    Opron K; Begley LA; Erb-Downward JR; Li G; Alexis NE; Barjaktarevic I; Barr RG; Bleecker ER; Boucher R; Bowler RP; Christenson SA; Comellas AP; Criner G; Cooper CB; Couper D; Galban CJ; Han MK; Hastie A; Hatt C; Hoffman EA; Kaner RJ; Kesimer M; Krishnan JA; LaFon DC; Martinez FJ; Ortega VE; Peters SP; Paine R; Putcha N; Woodruff PG; Huffnagle GB; Kozik AJ; Curtis JL; Huang YJ;
    Am J Respir Crit Care Med; 2024 Jul; 210(2):186-200. PubMed ID: 38261629
    [No Abstract]   [Full Text] [Related]  

  • 31. The metabolic footprint of the airway bacterial community in cystic fibrosis.
    Narayanamurthy V; Sweetnam JM; Denner DR; Chen LW; Naureckas ET; Laxman B; White SR
    Microbiome; 2017 Jun; 5(1):67. PubMed ID: 28666467
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of sputum microbiome with clinical outcome of initial antibiotic treatment in hospitalized patients with acute exacerbations of COPD.
    Liu H; Zheng D; Lin Y; Liu Z; Liang Z; Su J; Chen R; Zhou H; Wang Z
    Pharmacol Res; 2020 Oct; 160():105095. PubMed ID: 32730904
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Untargeted Metagenomic Investigation of the Airway Microbiome of Cystic Fibrosis Patients with Moderate-Severe Lung Disease.
    Bacci G; Taccetti G; Dolce D; Armanini F; Segata N; Di Cesare F; Lucidi V; Fiscarelli E; Morelli P; Casciaro R; Negroni A; Mengoni A; Bevivino A
    Microorganisms; 2020 Jul; 8(7):. PubMed ID: 32635564
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assessment of airway microbiota and inflammation in cystic fibrosis using multiple sampling methods.
    Zemanick ET; Wagner BD; Robertson CE; Stevens MJ; Szefler SJ; Accurso FJ; Sagel SD; Harris JK
    Ann Am Thorac Soc; 2015 Feb; 12(2):221-9. PubMed ID: 25474078
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Severe Achromobacter xylosoxidans infection and loss of sputum bacterial diversity in an adult patient with cystic fibrosis.
    Talbot NP; Flight WG
    Paediatr Respir Rev; 2016 Aug; 20 Suppl():27-9. PubMed ID: 27374622
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sputum microbiome profiling in COPD: beyond singular pathogen detection.
    Ditz B; Christenson S; Rossen J; Brightling C; Kerstjens HAM; van den Berge M; Faiz A
    Thorax; 2020 Apr; 75(4):338-344. PubMed ID: 31996401
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sputum biomarker profiles in cystic fibrosis (CF) and chronic obstructive pulmonary disease (COPD) and association between pulmonary function.
    Eickmeier O; Huebner M; Herrmann E; Zissler U; Rosewich M; Baer PC; Buhl R; Schmitt-Grohé S; Zielen S; Schubert R
    Cytokine; 2010 May; 50(2):152-7. PubMed ID: 20181491
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reducing human DNA bias in cystic fibrosis airway specimens for microbiome analysis.
    Klosinska K; Reece E; Kenny E; Renwick J
    J Microbiol Methods; 2022 Sep; 200():106540. PubMed ID: 35853495
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Different Microbiome Gene Repertoire in the Airways of Cystic Fibrosis Patients with Severe Lung Disease.
    Bacci G; Mengoni A; Fiscarelli E; Segata N; Taccetti G; Dolce D; Paganin P; Morelli P; Tuccio V; De Alessandri A; Lucidi V; Bevivino A
    Int J Mol Sci; 2017 Jul; 18(8):. PubMed ID: 28758937
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characteristics of the sputum microbiome in COPD exacerbations and correlations between clinical indices.
    Su L; Qiao Y; Luo J; Huang R; Li Z; Zhang H; Zhao H; Wang J; Xiao Y
    J Transl Med; 2022 Feb; 20(1):76. PubMed ID: 35123490
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.